Logo

TM Bioscience Issues Warrants for $14.4M

Dec 18, 1998
Premium

TORONTO--TM Biosciences announced that is has agreed, subject to regulatory approval, to issue up to 18 million special warrants on a private placement basis at 80 cents per special warrant, for aggregate gross proceeds of $14.4 million. The issue and sale of more than 12 million of the special warrants for proceeds of $10.1 million will be by way of a private placement underwritten by Yorkton Securities. The remaining warrants will be purchased by Canadian Medical Discoveries Fund for proceeds of $4.3 million. TM designs, develops, and commercializes DNA products for medical diagnostics, therapeutics, biochips, functional genomics, and bioinformatics.

Filed under

Informatics
Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.